The complete version of the NCCN Guidelines for Rectal Cancer, available online at NCCN.org, covers additional topics including risk assessment, pathology and staging, management of metastatic disease, posttreatment surveillance, treatment of recurrent disease, and survivorship.Al B. Benson III...
NCCN Guidelinesand this illustration may not be reproduced in any form without the express written permission of NCCN. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines?) Rectal Cancer Version 1.2021 — December 22, 2020 NCCN.org NCCN Guidelines for Patients? available at /patients ...
NCCNGuidelines™Version4.2011PanelMembers RectalCancer LeonardSaltz,MD†‡Þ MemorialSloan-KetteringCancerCenter SunilSharma,MD† HuntsmanCancerInstituteattheUniversity ofUtah DavidShibata,MD¶ H.LeeMoffittCancerCenterandResearch Institute TheUniversityofTexasMDAndersonCancer ...
However, NCCN and ESMO treatment guidelines, besides not recommending restaging after neoadjuvant therapy, still consider cTNM staging as an indicator for such therapy whereas recent studies demonstrate that high definition MRI with accurate staging of CRM, may be a better predictor for both local ...
National Comprehensive Cancer Network. Rectal Cancer (Version 2.2019).https://www.nccn.org/professionals/physician_gls/PDF/rectal.pdf. Accessed 4 June 2019. Bonjer HJ, Deijen CL, Abis GA, Cuesta MA, Pas MHVD, Klerk ESDL-D, et al. A randomized trial of laparoscopic versus open surgery for...
NCCN Clinical Practice Guideline in Oncology. Rectal Cancer, Version 1, 2021. National Comprehensive Cancer Network [EB/OL]. https://www.nccn.org. Chinese W. Wait database research cooperation G, Chinese Association of Surgeons CSoCCMDA, et al. [consensus on the watch and wait policy in r...
Objective To investigate the clinical value of transrectal ultrasonography in preoperative staging of rectal cancer.Methods Of the 118 colorectal cancer pa... X Li,J Huang - 《Journal of Colorectal & Anal Surgery》 被引量: 3发表: 2014年 Rectal Cancer, Version 2.2022, NCCN Clinical Practice Guide...
There was more T3-4 rectal cancer (97.09% vs 55.55%) and N1-2 rectal cancer (80.65% vs 38.09%) in the PNI-positive group than in the PNI-negative group (both P < 0.05). However, the radiomics model was established preoperatively, N staging wouldn’t be contained in the ...
Benson AB, et al. Rectal cancer, version 2.2018, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2018;16(7):874–901. PubMed CentralGoogle Scholar Adam IJ, et al. Role of circumferential margin involvement in the local recurrence of rectal cancer. Lancet. 1994;344...
NCCN: National Comprehensive Cancer Network nCRT: Neoadjuvant chemoradiotherapy NF-YA: Nuclear transcription factor Y subunit alpha NHEJ: Non–homologous end joining NP: Nanoparticle MAPK: Mitogen–Activated Protein Kinase MLH1: MutL Homolog 1